Videos / Protein based COVID-19 vaccine
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Practical Strategies to Increase Vaccination Rates This Flu Season

MRAs for Heart Failure Update - New Developments

Abnormal LFTs – Practical Cases Expert Q&A

COPD Exacerbation – Inhaled steroids vs Pneumonia Risks – It's Not Black and White

expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland